2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine

C103H90Br5N27O8S2 — CID 157272594

IUPAC2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine
SMILESNc1c(Br)c(C2CCC(C(=O)C(=O)O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCN(C=O)C2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCN(C=O)C2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCS(=O)(=O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCS(=O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12
InChIInChI=1S/C23H20BrN5O3.2C20H17BrN6O.C20H18BrN5O2S.C20H18BrN5OS/c24-18-19(12-5-7-13(8-6-12)20(30)23(31)32)28-22-16(11-27-29(22)21(18)25)15-9-14-3-1-2-4-17(14)26-10-15;2*21-17-18(13-5-6-26(10-13)11-28)25-20-15(9-24-27(20)19(17)22)14-7-12-3-1-2-4-16(12)23-8-14;21-17-18(12-5-7-29(27,28)8-6-12)25-20-15(11-24-26(20)19(17)22)14-9-13-3-1-2-4-16(13)23-10-14;21-17-18(12-5-7-28(27)8-6-12)25-20-15(11-24-26(20)19(17)22)14-9-13-3-1-2-4-16(13)23-10-14/h1-4,9-13H,5-8,25H2,(H,31,32);2*1-4,7-9,11,13H,5-6,10,22H2;1-4,9-12H,5-8,22H2;1-4,9-12H,5-8,22H2
InChIKeyAYSGLEBDBPZUQU-UHFFFAOYSA-N
MW2297.69 g/mol
LogP18.18
Rot. Bonds14

About 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine

2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine (PubChem CID 157272594) has the molecular formula C103H90Br5N27O8S2 and a molecular weight of 2297.69 g/mol. Its IUPAC name is 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine.

Molecular Properties

Compound Name2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine
PubChem CID157272594
Molecular FormulaC103H90Br5N27O8S2
Molecular Weight2297.69 g/mol
Exact Mass2291.28
IUPAC Name2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine
SMILESNc1c(Br)c(C2CCC(C(=O)C(=O)O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCN(C=O)C2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCN(C=O)C2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCS(=O)(=O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCS(=O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12
InChIInChI=1S/C23H20BrN5O3.2C20H17BrN6O.C20H18BrN5O2S.C20H18BrN5OS/c24-18-19(12-5-7-13(8-6-12)20(30)23(31)32)28-22-16(11-27-29(22)21(18)25)15-9-14-3-1-2-4-17(14)26-10-15;2*21-17-18(13-5-6-26(10-13)11-28)25-20-15(9-24-27(20)19(17)22)14-7-12-3-1-2-4-16(12)23-8-14;21-17-18(12-5-7-29(27,28)8-6-12)25-20-15(11-24-26(20)19(17)22)14-9-13-3-1-2-4-16(13)23-10-14;21-17-18(12-5-7-28(27)8-6-12)25-20-15(11-24-26(20)19(17)22)14-9-13-3-1-2-4-16(13)23-10-14/h1-4,9-13H,5-8,25H2,(H,31,32);2*1-4,7-9,11,13H,5-6,10,22H2;1-4,9-12H,5-8,22H2;1-4,9-12H,5-8,22H2
InChIKeyAYSGLEBDBPZUQU-UHFFFAOYSA-N
XLogP18.18
TPSA491.70 Ų
H-Bond Donors6
H-Bond Acceptors32
Rotatable Bonds14
Heavy Atoms145
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002297.69
LogP ≤ 518.18
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine?
The IUPAC name of 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine (CID 157272594) is 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine.
What is the SMILES notation for 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine?
The canonical SMILES for 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine is Nc1c(Br)c(C2CCC(C(=O)C(=O)O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCN(C=O)C2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCN(C=O)C2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCS(=O)(=O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12.Nc1c(Br)c(C2CCS(=O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12.
What is the InChIKey of 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine?
The InChIKey is AYSGLEBDBPZUQU-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H20BrN5O3.2C20H17BrN6O.C20H18BrN5O2S.C20H18BrN5OS/c24-18-19(12-5-7-13(8-6-12)20(30)23(31)32)28-22-16(11-27-29(22)21(18)25)15-9-14-3-1-2-4-17(14)26-10-15;2*21-17-18(13-5-6-26(10-13)11-28)25-20-15(9-24-27(20)19(17)22)14-7-12-3-1-2-4-16(12)23-8-14;21-17-18(12-5-7-29(27,28)8-6-12)25-20-15(11-24-26(20)19(17)22)14-9-13-3-1-2-4-16(13)23-10-14;21-17-18(12-5-7-28(27)8-6-12)25-20-15(11-24-26(20)19(17)22)14-9-13-3-1-2-4-16(13)23-10-14/h1-4,9-13H,5-8,25H2,(H,31,32);2*1-4,7-9,11,13H,5-6,10,22H2;1-4,9-12H,5-8,22H2;1-4,9-12H,5-8,22H2.
What are the key properties of 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine?
2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine has a molecular weight of 2297.69 g/mol, XLogP of 18.18, 14 rotatable bonds, 6 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]-2-oxoacetic acid;bis(3-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)pyrrolidine-1-carbaldehyde);6-bromo-5-(1,1-dioxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(1-oxothian-4-yl)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine is sourced from PubChem (CID 157272594), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).